Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trisha M Wise-Draper

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Molecular Therapy. Methods & Clinical Development|April 5, 2021
Targeted knockdown of the adenosine A<sub>2A</sub> receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cellsHannah S Newton, Ameet A Chimote, Michael J Arnold, et al.
Frontiers in Pharmacology|March 19, 2020
A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8<sup>+</sup> T Cells in Head and Neck CancerAmeet A Chimote, Vaibhavkumar S Gawali, Hannah S Newton, et al.
Cancers|July 27, 2022
How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor ImmunityMartina Chirra, Hannah S Newton, Vaibhavkumar S Gawali, et al.
Head & Neck|August 10, 2020
Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patientLuke M Lewis, Alice L Tang, Trisha M Wise-Draper, et al.
Molecular and Cellular Biology|August 9, 2006
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functionsTrisha M Wise-Draper, Hillary V Allen, Elizabeth E Jones, et al.
Lab on a Chip|January 19, 2026
Label-free monitoring of therapy response in 3D spheroids using lab-on-a-chip impedance spectroscopyGregory Macke, Maulee Sheth, Manju Sharma, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 12, 2012
Future directions and treatment strategies for head and neck squamous cell carcinomasTrisha M Wise-Draper, David J Draper, J Silvio Gutkind, et al.
Head & Neck|August 7, 2021
Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II studyPaul J Kreinbrink, Michelle L Mierzwa, Brad Huth, et al.
Head & Neck|June 17, 2025
Treatment Effect Estimation With Potential Outcomes for a Single-Arm Trial Compared With Historical Controls: A Case Study of Locally Recurrent Head and Neck Squamous Cell Carcinoma Patients Treated With Adjuvant NivolumabNusrat Harun, Rodney Sparapani, Purushottam W Laud, et al.
Journal of Virology|October 29, 2005
The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7Trisha M Wise-Draper, Hillary V Allen, Megan N Thobe, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Molecular Therapy. Methods & Clinical Development|April 5, 2021
Targeted knockdown of the adenosine A<sub>2A</sub> receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cellsHannah S Newton, Ameet A Chimote, Michael J Arnold, et al.
Frontiers in Pharmacology|March 19, 2020
A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8<sup>+</sup> T Cells in Head and Neck CancerAmeet A Chimote, Vaibhavkumar S Gawali, Hannah S Newton, et al.
Cancers|July 27, 2022
How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor ImmunityMartina Chirra, Hannah S Newton, Vaibhavkumar S Gawali, et al.
Head & Neck|August 10, 2020
Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patientLuke M Lewis, Alice L Tang, Trisha M Wise-Draper, et al.
Molecular and Cellular Biology|August 9, 2006
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functionsTrisha M Wise-Draper, Hillary V Allen, Elizabeth E Jones, et al.
Lab on a Chip|January 19, 2026
Label-free monitoring of therapy response in 3D spheroids using lab-on-a-chip impedance spectroscopyGregory Macke, Maulee Sheth, Manju Sharma, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 12, 2012
Future directions and treatment strategies for head and neck squamous cell carcinomasTrisha M Wise-Draper, David J Draper, J Silvio Gutkind, et al.
Head & Neck|August 7, 2021
Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II studyPaul J Kreinbrink, Michelle L Mierzwa, Brad Huth, et al.
Head & Neck|June 17, 2025
Treatment Effect Estimation With Potential Outcomes for a Single-Arm Trial Compared With Historical Controls: A Case Study of Locally Recurrent Head and Neck Squamous Cell Carcinoma Patients Treated With Adjuvant NivolumabNusrat Harun, Rodney Sparapani, Purushottam W Laud, et al.
Journal of Virology|October 29, 2005
The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7Trisha M Wise-Draper, Hillary V Allen, Megan N Thobe, et al.
Pageof 8